William A. Hagstrom

Cofactor Genomics, Inc. operates as a biotech company that offers services to the life-science, pharmaceutical, agriculture, and biofuels companies. The firm provides human genome projects. The company was founded by Jarret Glasscock, Dave Messina, and Jon Armstrong in 2008 and is headquartered in San Francisco, CA.

ZymeTx, Inc is a biotechnology company, which is engaged in the discovery, development and commercialization of products used to diagnose and treat viruses. The company's ViraZme technology focuses on the development of molecules that interacts with an enzyme of specific origin, such as viral, mammalian or bacterial origin. It was founded in 1994 and is headquartered in Oklahoma City, OK.

Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA.

ZymeTx, Inc is a biotechnology company, which is engaged in the discovery, development and commercialization of products used to diagnose and treat viruses. The company's ViraZme technology focuses on the development of molecules that interacts with an enzyme of specific origin, such as viral, mammalian or bacterial origin. It was founded in 1994 and is headquartered in Oklahoma City, OK.

ZymeTx, Inc is a biotechnology company, which is engaged in the discovery, development and commercialization of products used to diagnose and treat viruses. The company's ViraZme technology focuses on the development of molecules that interacts with an enzyme of specific origin, such as viral, mammalian or bacterial origin. It was founded in 1994 and is headquartered in Oklahoma City, OK.

UroCor, Inc. provides diagnostic and therapeutic services for urological disorders. It helps in detecting, diagnosing, treating & managing- prostate cancer, bladder cancer, kidney stones, and other complex urologic disorders. The company is located in Oklahoma City, OK

ZymeTx, Inc is a biotechnology company, which is engaged in the discovery, development and commercialization of products used to diagnose and treat viruses. The company's ViraZme technology focuses on the development of molecules that interacts with an enzyme of specific origin, such as viral, mammalian or bacterial origin. It was founded in 1994 and is headquartered in Oklahoma City, OK.

ZymeTx, Inc is a biotechnology company, which is engaged in the discovery, development and commercialization of products used to diagnose and treat viruses. The company's ViraZme technology focuses on the development of molecules that interacts with an enzyme of specific origin, such as viral, mammalian or bacterial origin. It was founded in 1994 and is headquartered in Oklahoma City, OK.

ZymeTx, Inc is a biotechnology company, which is engaged in the discovery, development and commercialization of products used to diagnose and treat viruses. The company's ViraZme technology focuses on the development of molecules that interacts with an enzyme of specific origin, such as viral, mammalian or bacterial origin. It was founded in 1994 and is headquartered in Oklahoma City, OK.

ZymeTx, Inc is a biotechnology company, which is engaged in the discovery, development and commercialization of products used to diagnose and treat viruses. The company's ViraZme technology focuses on the development of molecules that interacts with an enzyme of specific origin, such as viral, mammalian or bacterial origin. It was founded in 1994 and is headquartered in Oklahoma City, OK.

ZymeTx, Inc is a biotechnology company, which is engaged in the discovery, development and commercialization of products used to diagnose and treat viruses. The company's ViraZme technology focuses on the development of molecules that interacts with an enzyme of specific origin, such as viral, mammalian or bacterial origin. It was founded in 1994 and is headquartered in Oklahoma City, OK.

Cofactor Genomics, Inc. operates as a biotech company that offers services to the life-science, pharmaceutical, agriculture, and biofuels companies. The firm provides human genome projects. The company was founded by Jarret Glasscock, Dave Messina, and Jon Armstrong in 2008 and is headquartered in San Francisco, CA.

Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA.

Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA.

ZymeTx, Inc is a biotechnology company, which is engaged in the discovery, development and commercialization of products used to diagnose and treat viruses. The company's ViraZme technology focuses on the development of molecules that interacts with an enzyme of specific origin, such as viral, mammalian or bacterial origin. It was founded in 1994 and is headquartered in Oklahoma City, OK.

Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA.

Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA.

Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA.

Genalyte, Inc. specializes in instrumentation and multiplex assays for biomarker and protein detection. The firm offers autoantibody testing assays for autoimmune research, custom assay services and maverick detection system. The company was founded in 2007 by Lawrence Cary Gunn III and is headquartered in San Diego, CA.

ZymeTx, Inc is a biotechnology company, which is engaged in the discovery, development and commercialization of products used to diagnose and treat viruses. The company's ViraZme technology focuses on the development of molecules that interacts with an enzyme of specific origin, such as viral, mammalian or bacterial origin. It was founded in 1994 and is headquartered in Oklahoma City, OK.

Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA.

Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA.

ZymeTx, Inc is a biotechnology company, which is engaged in the discovery, development and commercialization of products used to diagnose and treat viruses. The company's ViraZme technology focuses on the development of molecules that interacts with an enzyme of specific origin, such as viral, mammalian or bacterial origin. It was founded in 1994 and is headquartered in Oklahoma City, OK.

Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA.

Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA.

Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA.